Jan 21, 2021
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Nov 13, 2020
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Sep 25, 2020
Radius Health & Menarini Group Provide Elacestrant Update
Sep 02, 2020
Announced The XXIV Edition Of The International Fair Play Menarini Award
Jul 23, 2020
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
Jun 10, 2020
Menarini Group Completes a Solid Year of Operating Performance
Apr 16, 2020
Fondazione Internazionale Menarini Creates a New Covid-19 "Virtual" Library for Doctors and Nurses: It Takes Only a Click to get the Studies Chosen by Nobel Ignarro
Mar 16, 2020
Covid-19: Menarini Group Converts Production Plant to Produce and Donate Disinfectant Gel
Jan 30, 2020
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Oct 24, 2019
Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of "Fondazione Internazionale Menarini"
Sep 12, 2019
Menarini: Elcin Barker Ergun Group CEO
Jul 16, 2019
The Menarini Group Celebrates the Champions of Fair Play
Dec 21, 2018
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
Oct 25, 2018
Menarini Launches "Pills of Art"
Oct 12, 2018
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries